Michael Weaver
机构: University of Texas Health Science Center at Houston
每年引用次数
引用次数
引用: 3,885
H-指数: 31
I10-指数 : 50
出版物: 123
Transdermal nicotine-induced tobacco abstinence symptom suppression: nicotine dose and smokers' gender.
Sarah E. Evans , Melissa Blank , Cynthia Sams , Michael F. Weaver
Experimental and Clinical Psychopharmacology 14 ( 2) 121 -135
49
2006
The influence of transdermal nicotine on tobacco/nicotine abstinence and the effects of a concurrently administered cigarette in women and men.
Bethea A. Kleykamp , Janine M. Jennings , Cynthia Sams , Michael F. Weaver
Experimental and Clinical Psychopharmacology 16 ( 2) 99 -112
24
2008
Clinical laboratory assessment of the abuse liability of an electronic cigarette
Andrea R. Vansickel , Michael F. Weaver , Thomas Eissenberg
Addiction 107 ( 8) 1493 -1500
122
2012
Differential success rates in racial groups: Results of a clinical trial of smoking cessation among female prisoners
Karen L. Cropsey , Michael F. Weaver , Gloria D. Eldridge , Gabriela C. Villalobos
Nicotine & Tobacco Research 11 ( 6) 690 -697
33
2009
PPAR‐gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double‐blind randomized controlled pilot trial
Joy M. Schmitz , Charles E. Green , Khader M. Hasan , Jessica Vincent
Addiction 112 ( 10) 1861 -1868
34
2017
Role of the Primary Care Physician in Problems of Substance Abuse
Michael F. Weaver , Margaret A. E. Jarvis , Sidney H. Schnoll
Archives of Internal Medicine 159 ( 9) 913 -924
58
1999
Screening for Psychotherapeutic Medication Misuse in Primary Care Patients: Comparing Two Instruments.
Sebastian T. Tong , Kathryn M. Polak , Michael F. Weaver , Gabriela C. Villalobos
Journal of the American Board of Family Medicine 32 ( 2) 272 -278
1
2019
Addiction and Pain
Sidney H. Schnoll , Michael F. Weaver
The American Journal on Addictions 12 ( 2) S27 -S35
32
2003
Cocaine-specific speed-accuracy trade-off during anti-saccade testing differentiates patients with cocaine use disorder who achieve initial abstinence during treatment.
Robert Suchting , Luba Yammine , Angela L Stotts , Scott D Lane
Journal of Psychopharmacology 35 ( 5) 611 -614
2021
Cannabis use a co-existing condition in admitted first episode bipolar patients
Terrence T. Currie , Jane E Hamilton , Michael F Weaver , Chase J Findley
Journal of Affective Disorders 254 132
2019
Designer drugs 2015: assessment and management.
Michael F Weaver , John A Hopper , Erik W Gunderson
Addiction Science & Clinical Practice 10 ( 1) 8 -8
74
2015
Prevalence and impact of alcohol and other drug use disorders on sedation and mechanical ventilation: a retrospective study
Marjolein de Wit , Sau Yin Wan , Sujoy Gill , Wendy I Jenvey
BMC Anesthesiology 7 ( 1) 3 -3
44
2007
Feasibility of Exenatide, a GLP-1R Agonist, for Treating Cocaine Use Disorder: A Case Series Study
Luba Yammine , Jessica C Balderas , Michael F Weaver , Joy M Schmitz
Journal of Addiction Medicine 10 -1097
2023
Exenatide as an adjunct to nicotine patch for smoking cessation and prevention of postcessation weight gain among treatment-seeking smokers with pre-diabetes and/or overweight: study protocol for a randomised, placebo-controlled clinical trial
Luba Yammine , Christopher D Verrico , Francesco Versace , Heather E Webber
BMJ open 13 ( 6) e072707 -e072707
2
2023
Contingency management plus acceptance and commitment therapy for initial cocaine abstinence: Results of a sequential multiple assignment randomized trial (SMART)
Joy M Schmitz , Angela L Stotts , Anka A Vujanovic , Jin H Yoon
Drug and Alcohol Dependence 256 111078 -111078
2
2024
Stimulants and related drugs
Thomas R Kosten , Mehmet Sofuoglu , Michael F Weaver , Sidney H Schnoll
Gabbard's Treatments of Psychiatric Disorders 263 -263
4
2007
Targeting white matter neuroprotection as a relapse prevention strategy for treatment of cocaine use disorder: Design of a mechanism-focused randomized clinical trial
Joy M Schmitz , Scott D Lane , Michael F Weaver , Ponnada A Narayana
Contemporary clinical trials 111 106603 -106603
2021
Naltrexone plus bupropion reduces cigarette smoking in individuals with methamphetamine use disorder: A secondary analysis from the CTN ADAPT-2 trial
Joy M Schmitz , Angela L Stotts , Jin H Yoon , Thomas F Northrup
Journal of Substance Use and Addiction Treatment 151 208987 -208987
3
2023
Comparison of puff topography, toxicant exposure, and subjective effects in low-and high-frequency waterpipe users: a double-blind, placebo-control study
Caroline O Cobb , Melissa D Blank , Alejandra Morlett , Alan Shihadeh
Nicotine & Tobacco Research 17 ( 6) 667 -674
31
2014
Prescription fill patterns for benzodiazepine and opioid drugs during the COVID-19 pandemic in the United States
Constanza de Dios , Brisa S Fernandes , Kristine Whalen , Shruti Bandewar
Drug and alcohol dependence 229 109176 -109176
19
2021